@FollowTheFiling

the plan is simple: following the filings

FollowTheFilings.com
Joined August 2024
  • Tweets672
  • Following4
  • Followers1.3K
$KO Q3 Recap:
21
$KO Q3: BEAT ON EPS AND REVENUE Adj EPS $0.91 vs $0.88 est (+3%) Revenue $13.40B vs $12.92B est (+4%)
EARNINGS, OCT 27. KO, Coca-Cola, Q3 2026. Adjusted EPS $0.91, estimate $0.88: BEAT +3.3%. Revenue $13.40B, estimate $12.92B: BEAT +3.7%. From the company's 8-K, estimate: analyst consensus. followthefilings.com/earnings/KO.

ALT EARNINGS, OCT 27. KO, Coca-Cola, Q3 2026. Adjusted EPS $0.91, estimate $0.88: BEAT +3.3%. Revenue $13.40B, estimate $12.92B: BEAT +3.7%. From the company's 8-K, estimate: analyst consensus. followthefilings.com/earnings/KO.

21
One line, one lawsuit:
21
Who pays Anthropic's bills:
1
2
115
JUST FILED: JOHNSON & JOHNSON · Q3 · $762M Largest holding: $PTGX, 45.3% of the portfolio
Johnson & Johnson. 2026 Q3, $762M portfolio. Top 6 of 15 holdings, 92.3% of the portfolio: 1. PTGX (Protagonist Therapeutics), 45.3%; 2. NBTX (Nanobiotix), 23.0%; 3. MGTX (MeiraGTx), 9.6%; 4. RAPP (Rapport Therapeutics), 7.9%; 5. CTNM (Contineum Therapeutics), 3.5%; 6. CBRS (Cerebras Systems), 3.0%. SEC 13F filing, not investment advice. followthefilings.com.

ALT Johnson & Johnson. 2026 Q3, $762M portfolio. Top 6 of 15 holdings, 92.3% of the portfolio: 1. PTGX (Protagonist Therapeutics), 45.3%; 2. NBTX (Nanobiotix), 23.0%; 3. MGTX (MeiraGTx), 9.6%; 4. RAPP (Rapport Therapeutics), 7.9%; 5. CTNM (Contineum Therapeutics), 3.5%; 6. CBRS (Cerebras Systems), 3.0%. SEC 13F filing, not investment advice. followthefilings.com.

2
152
JUST FILED: GREENHAVEN ASSOCIATES · Q3 · $8B Added $142M of $LEN, now 13.4% of the portfolio
Greenhaven Associates. 2026 Q3, $8B portfolio. Bars: share of the portfolio traded since 2026 Q2. Bought: LEN (Lennar), Added, 11.8% to 13.4%; BDX (Becton Dickinson), Added, 9.9% to 13.3%; BBWI (Bath & Body Works), New, now 0.0%. Sold: ACN (Accenture), Exited, was 4.9%; LEA (Lear), Trimmed, 2.3% to 1.2%; EPAM (EPAM Systems), Exited, was 0.5%. SEC 13F filing, not investment advice. followthefilings.com.

ALT Greenhaven Associates. 2026 Q3, $8B portfolio. Bars: share of the portfolio traded since 2026 Q2. Bought: LEN (Lennar), Added, 11.8% to 13.4%; BDX (Becton Dickinson), Added, 9.9% to 13.3%; BBWI (Bath & Body Works), New, now 0.0%. Sold: ACN (Accenture), Exited, was 4.9%; LEA (Lear), Trimmed, 2.3% to 1.2%; EPAM (EPAM Systems), Exited, was 0.5%. SEC 13F filing, not investment advice. followthefilings.com.

30
One share, half the vote:
1
88
Anthropics lock up, visualized:
3
168
JUST FILED: OLD REPUBLIC INTERNATIONAL · Q3 · $2.2B Trimmed $46.1M of $MSCI, now 0.2% of the portfolio
Old Republic International. 2026 Q3, $2.2B portfolio. Bars: share of the portfolio traded since 2026 Q2. Bought: SPYM (SPDR Series Trust), New, now 0.3%. Sold: MSCI (MSC Industrial Direct), Trimmed, 1.8% to 0.2%; ETN (Eaton), Trimmed, 3.2% to 2.1%; CAT (Caterpillar), Trimmed, 3.4% to 1.7%; CMI (Cummins), Trimmed, 3.2% to 1.7%; VLO (Valero Energy), Trimmed, 1.9% to 2.9%. SEC 13F filing, not investment advice. followthefilings.com.

ALT Old Republic International. 2026 Q3, $2.2B portfolio. Bars: share of the portfolio traded since 2026 Q2. Bought: SPYM (SPDR Series Trust), New, now 0.3%. Sold: MSCI (MSC Industrial Direct), Trimmed, 1.8% to 0.2%; ETN (Eaton), Trimmed, 3.2% to 2.1%; CAT (Caterpillar), Trimmed, 3.4% to 1.7%; CMI (Cummins), Trimmed, 3.2% to 1.7%; VLO (Valero Energy), Trimmed, 1.9% to 2.9%. SEC 13F filing, not investment advice. followthefilings.com.

1
60
$ANT S-1 Deep Dive: Anthropic's revenue was ~$16.3B in H1 2026, up from ~$1.2B in H1 2025. Its GAAP net loss was ~$81B and non-GAAP adjusted net income ~$2.7B. Also covered: compute costs, the cash pile, the cloud commitments, the trust that elects the board, and Class F votes. Follow the filings, connect the dots.
1
4
96
Load more